SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001553350-17-001202
Filing Date
2017-11-13
Accepted
2017-11-13 07:01:16
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT htbx_10q.htm 10-Q 470858
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER htbx_ex31z1.htm EX-31.1 10952
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER htbx_ex31z2.htm EX-31.2 10941
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER htbx_ex32z1.htm EX-32.1 4693
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER htbx_ex32z2.htm EX-32.2 4565
  Complete submission text file 0001553350-17-001202.txt   2861899

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE htbx-20170930.xml EX-101.INS 423798
7 XBRL SCHEMA FILE htbx-20170930.xsd EX-101.SCH 33985
8 XBRL CALCULATION FILE htbx-20170930_cal.xml EX-101.CAL 61829
9 XBRL DEFINITION FILE htbx-20170930_def.xml EX-101.DEF 100922
10 XBRL LABEL FILE htbx-20170930_lab.xml EX-101.LAB 293667
11 XBRL PRESENTATION FILE htbx-20170930_pre.xml EX-101.PRE 212629
Mailing Address 801 CAPITOLA DRIVE DURHAM NC 27713
Business Address 801 CAPITOLA DRIVE DURHAM NC 27713 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 171193008
SIC: 2834 Pharmaceutical Preparations